Cardiovascular Disease / Atherosclerotic Cardiovascular Disease
Indication
Atherosclerotic Cardiovascular Disease
Assets addressing this indication.
Total attributable cost
$381.0B
$19,145/patient
Drug spend
$22.7B
$1,139/patient
6% of total cost is drugs
All severities (2015-2018 NHANES cycle) · US